{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T00:17:31Z","timestamp":1790900251984,"version":"4.1.0"},"reference-count":119,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Cancer"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.trecan.2023.01.002","type":"journal-article","created":{"date-parts":[[2023,2,2]],"date-time":"2023-02-02T17:29:16Z","timestamp":1675358956000},"page":"326-338","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["Everybody needs good neighbours: the progressive DCIS microenvironment"],"prefix":"10.1016","volume":"9","author":[{"given":"Shayin V.","family":"Gibson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza M.","family":"Roozitalab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael D.","family":"Allen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Louise","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward P.","family":"Carter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4738-0173","authenticated-orcid":false,"given":"Richard P.","family":"Grose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.trecan.2023.01.002_bb0005","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1002\/cncr.20979","article-title":"Outcome of patients with ductal carcinoma in situ untreated after diagnostic biopsy: results from the Nurses' Health Study","volume":"103","author":"Collins","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.trecan.2023.01.002_bb0010","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1002\/cncr.21069","article-title":"The natural history of low-grade ductal carcinoma in situ of the breast in women treated by biopsy only revealed over 30 years of long-term follow-up","volume":"103","author":"Sanders","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.trecan.2023.01.002_bb0015","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1016\/S0140-6736(12)61611-0","article-title":"The benefits and harms of breast cancer screening: an independent review","volume":"380","author":"Independent UK Panel on Breast Cancer Screening","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.trecan.2023.01.002_bb0020","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1093\/jnci\/djp485","article-title":"National Institutes of Health State-of-the-Science Conference statement: diagnosis and management of ductal carcinoma in situ September 22\u201324, 2009","volume":"102","author":"Allegra","year":"2010","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.trecan.2023.01.002_bb0025","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s10549-005-9101-z","article-title":"The natural history of ductal carcinoma in situ of the breast: a review","volume":"97","author":"Erbas","year":"2006","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.trecan.2023.01.002_bb0030","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.maturitas.2010.12.008","article-title":"DCIS of the breast: are we over-diagnosing it? Are we over-treating it?","volume":"68","author":"Leeper","year":"2011","journal-title":"Maturitas"},{"key":"10.1016\/j.trecan.2023.01.002_bb0035","doi-asserted-by":"crossref","first-page":"4545","DOI":"10.3390\/cancers14194545","article-title":"De-escalating the management of in situ and invasive breast cancer","volume":"14","author":"Angarita","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.trecan.2023.01.002_bb0040","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/s41568-022-00512-y","article-title":"Learning to distinguish progressive and non-progressive ductal carcinoma in situ","volume":"22","author":"Casasent","year":"2022","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.trecan.2023.01.002_bb0045","doi-asserted-by":"crossref","first-page":"3259","DOI":"10.3390\/cancers14133259","article-title":"Prediction models and decision aids for women with ductal carcinoma in situ: a systematic literature review","volume":"14","author":"Schmitz","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.trecan.2023.01.002_bb0050","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.ejca.2018.06.027","article-title":"Management and 5-year outcomes in 9938 women with screen-detected ductal carcinoma in situ: the UK Sloane Project","volume":"101","author":"Thompson","year":"2018","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.trecan.2023.01.002_bb0055","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1159\/000319625","article-title":"Progression of ductal carcinoma in situ from the pathological perspective","volume":"5","author":"Cunha","year":"2010","journal-title":"Breast Care (Basel)"},{"key":"10.1016\/j.trecan.2023.01.002_bb0060","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/s10549-016-3973-y","article-title":"Subsequent risk of ipsilateral and contralateral invasive breast cancer after treatment for ductal carcinoma in situ: incidence and the effect of radiotherapy in a population-based cohort of 10,090 women","volume":"159","author":"Elshof","year":"2016","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.trecan.2023.01.002_bb0065","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1093\/jnci\/djq101","article-title":"Biomarker expression and risk of subsequent tumors after initial ductal carcinoma in situ diagnosis","volume":"102","author":"Kerlikowske","year":"2010","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.trecan.2023.01.002_bb0070","doi-asserted-by":"crossref","first-page":"5317","DOI":"10.1158\/1078-0432.CCR-21-1239","article-title":"Prognostic and predictive value of HER2 expression in ductal carcinoma in situ: results from the UK\/ANZ DCIS randomized trial","volume":"27","author":"Thorat","year":"2021","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.trecan.2023.01.002_bb0075","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1093\/annonc\/mdv013","article-title":"Risk of subsequent in situ and invasive breast cancer in human epidermal growth factor receptor 2-positive ductal carcinoma in situ","volume":"26","author":"Curigliano","year":"2015","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.trecan.2023.01.002_bb0080","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1200\/JCO.20.02824","article-title":"Comparison of radiation with or without concurrent trastuzumab for HER2-positive ductal carcinoma in situ resected by lumpectomy: a phase III clinical trial","volume":"39","author":"Cobleigh","year":"2021","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.trecan.2023.01.002_bb0085","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-026797","article-title":"The COMET (Comparison of Operative versus Monitoring and Endocrine Therapy) trial: a phase III randomised controlled clinical trial for low-risk ductal carcinoma in situ (DCIS)","volume":"9","author":"Hwang","year":"2019","journal-title":"BMJ Open"},{"key":"10.1016\/j.trecan.2023.01.002_bb0090","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1016\/j.ejca.2015.07.017","article-title":"Addressing overtreatment of screen detected DCIS; the LORIS trial","volume":"51","author":"Francis","year":"2015","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.trecan.2023.01.002_bb0095","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1016\/j.ejca.2015.05.008","article-title":"Feasibility of a prospective, randomised, open-label, international multicentre, phase III, non-inferiority trial to assess the safety of active surveillance for low risk ductal carcinoma in situ - The LORD study","volume":"51","author":"Elshof","year":"2015","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.trecan.2023.01.002_bb0100","doi-asserted-by":"crossref","first-page":"R87","DOI":"10.1186\/bcr2157","article-title":"Evidence that molecular changes in cells occur before morphological alterations during the progression of breast ductal carcinoma","volume":"10","author":"Castro","year":"2008","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.trecan.2023.01.002_bb0105","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/sj.bjc.6606021","article-title":"Molecular subtyping of DCIS: heterogeneity of breast cancer reflected in pre-invasive disease","volume":"104","author":"Clark","year":"2011","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.trecan.2023.01.002_bb0110","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20130077","article-title":"Ductal carcinoma in situ of the breast: morphological and molecular features implicated in progression","volume":"34","author":"Carraro","year":"2014","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.trecan.2023.01.002_bb0115","doi-asserted-by":"crossref","first-page":"R7","DOI":"10.1186\/bcr2222","article-title":"Gene expression profiling of the tumor microenvironment during breast cancer progression","volume":"11","author":"Ma","year":"2009","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.trecan.2023.01.002_bb0120","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.molonc.2010.06.007","article-title":"Molecular diversity in ductal carcinoma in situ (DCIS) and early invasive breast cancer","volume":"4","author":"Muggerud","year":"2010","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.trecan.2023.01.002_bb0125","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s10911-018-9409-z","article-title":"Breaking through to the other side: microenvironment contributions to DCIS initiation and progression","volume":"23","author":"Nelson","year":"2018","journal-title":"J. Mammary Gland Biol. Neoplasia"},{"key":"10.1016\/j.trecan.2023.01.002_bb0130","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/j.celrep.2016.06.051","article-title":"Molecular features of subtype-specific progression from ductal carcinoma in situ to invasive breast cancer","volume":"16","author":"Lesurf","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.trecan.2023.01.002_bb0135","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.cell.2021.12.023","article-title":"Transition to invasive breast cancer is associated with progressive changes in the structure and composition of tumor stroma","volume":"185","author":"Risom","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.trecan.2023.01.002_bb0140","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1186\/bcr1286","article-title":"Myoepithelial cells: good fences make good neighbors","volume":"7","author":"Adriance","year":"2005","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.trecan.2023.01.002_bb0145","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s10911-005-9586-4","article-title":"Myoepithelial cells: their origin and function in breast morphogenesis and neoplasia","volume":"10","author":"Gudjonsson","year":"2005","journal-title":"J. Mammary Gland Biol. Neoplasia"},{"key":"10.1016\/j.trecan.2023.01.002_bb0150","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0014-4800(03)00011-X","article-title":"Myoepithelial mRNA expression profiling reveals a common tumor-suppressor phenotype","volume":"74","author":"Barsky","year":"2003","journal-title":"Exp. Mol. Pathol."},{"key":"10.1016\/j.trecan.2023.01.002_bb0155","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1006\/excr.1998.4066","article-title":"The human myoepithelial cell exerts antiproliferative effects on breast carcinoma cells characterized by p21WAF1\/CIP1 induction, G2\/M arrest, and apoptosis","volume":"241","author":"Shao","year":"1998","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.trecan.2023.01.002_bb0160","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1126\/science.8290962","article-title":"Maspin, a serpin with tumor-suppressing activity in human mammary epithelial cells","volume":"263","author":"Zou","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.trecan.2023.01.002_bb0165","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1038\/ncb0901-823","article-title":"Desmosomal adhesion regulates epithelial morphogenesis and cell positioning","volume":"3","author":"Runswick","year":"2001","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.trecan.2023.01.002_bb0170","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s10911-005-9585-5","article-title":"Myoepithelial cells: autocrine and paracrine suppressors of breast cancer progression","volume":"10","author":"Barsky","year":"2005","journal-title":"J. Mammary Gland Biol. Neoplasia"},{"key":"10.1016\/j.trecan.2023.01.002_bb0175","doi-asserted-by":"crossref","first-page":"3368","DOI":"10.1083\/jcb.201802144","article-title":"Myoepithelial cells are a dynamic barrier to epithelial dissemination","volume":"217","author":"Sirka","year":"2018","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.trecan.2023.01.002_bb0180","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.molonc.2013.07.005","article-title":"Progression from ductal carcinoma in situ to invasive breast cancer: revisited","volume":"7","author":"Cowell","year":"2013","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.trecan.2023.01.002_bb0185","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s10911-005-9584-6","article-title":"Do myoepithelial cells hold the key for breast tumor progression?","volume":"10","author":"Polyak","year":"2005","journal-title":"J. Mammary Gland Biol. Neoplasia"},{"key":"10.1016\/j.trecan.2023.01.002_bb0190","doi-asserted-by":"crossref","first-page":"3076","DOI":"10.1016\/j.ajpath.2015.07.004","article-title":"Myoepithelial cell differentiation markers in ductal carcinoma in situ progression","volume":"185","author":"Russell","year":"2015","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.trecan.2023.01.002_bb0195","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ccr.2004.06.010","article-title":"Molecular characterization of the tumor microenvironment in breast cancer","volume":"6","author":"Allinen","year":"2004","journal-title":"Cancer Cell"},{"key":"10.1016\/j.trecan.2023.01.002_bb0200","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1038\/s41416-020-0797-7","article-title":"The prognostic significance of immune microenvironment in breast ductal carcinoma in situ","volume":"122","author":"Toss","year":"2020","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.trecan.2023.01.002_bb0205","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1038\/s41379-018-0040-8","article-title":"Prognostic significance of tumor-infiltrating lymphocytes in ductal carcinoma in situ of the breast","volume":"31","author":"Toss","year":"2018","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.trecan.2023.01.002_bb0210","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1093\/annonc\/mdw623","article-title":"The prevalence and clinical relevance of tumor-infiltrating lymphocytes (TILs) in ductal carcinoma in situ of the breast","volume":"28","author":"Pruneri","year":"2017","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.trecan.2023.01.002_bb0215","doi-asserted-by":"crossref","first-page":"5210","DOI":"10.1158\/1078-0432.CCR-17-0743","article-title":"Relationship of the breast ductal carcinoma in situ immune microenvironment with clinicopathological and genetic features","volume":"23","author":"Hendry","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.trecan.2023.01.002_bb0220","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1242\/jcs.115.1.39","article-title":"Normal and tumor-derived myoepithelial cells differ in their ability to interact with luminal breast epithelial cells for polarity and basement membrane deposition","volume":"115","author":"Gudjonsson","year":"2002","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.trecan.2023.01.002_bb0225","first-page":"109","article-title":"Mechanostimulation of breast myoepithelial cells induces functional changes associated with DCIS progression to invasion. npj","volume":"8","author":"Hayward","year":"2022","journal-title":"Breast Cancer"},{"key":"10.1016\/j.trecan.2023.01.002_bb0230","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1158\/1078-0432.CCR-13-1504","article-title":"Altered microenvironment promotes progression of preinvasive breast cancer: myoepithelial expression of alphavbeta6 integrin in DCIS identifies high-risk patients and predicts recurrence","volume":"20","author":"Allen","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.trecan.2023.01.002_bb0235","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s13058-017-0822-9","article-title":"Loss of MMP-8 in ductal carcinoma in situ (DCIS)-associated myoepithelial cells contributes to tumour promotion through altered adhesive and proteolytic function","volume":"19","author":"Sarper","year":"2017","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.trecan.2023.01.002_bb0240","doi-asserted-by":"crossref","first-page":"11466","DOI":"10.1074\/jbc.M117.775080","article-title":"Tumor-associated myoepithelial cells promote the invasive progression of ductal carcinoma in situ through activation of TGF\u03b2 signaling","volume":"292","author":"Lo","year":"2017","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.trecan.2023.01.002_bb0245","doi-asserted-by":"crossref","first-page":"5942","DOI":"10.1158\/0008-5472.CAN-14-1841","article-title":"\u03b1v\u03b26 Expression in myoepithelial cells: a novel marker for predicting DCIS progression with therapeutic potential","volume":"74","author":"Allen","year":"2014","journal-title":"Cancer Res."},{"key":"10.1016\/j.trecan.2023.01.002_bb0250","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/s41574-021-00487-0","article-title":"Metabolic pathways in obesity-related breast cancer","volume":"17","author":"Brown","year":"2021","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.trecan.2023.01.002_bb0255","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s10555-022-10043-5","article-title":"The obesity-breast cancer link: a multidisciplinary perspective","volume":"41","author":"Devericks","year":"2022","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.trecan.2023.01.002_bb0260","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1186\/s13046-018-0867-3","article-title":"IL-6-mediated cross-talk between human preadipocytes and ductal carcinoma in situ in breast cancer progression","volume":"37","author":"Kim","year":"2018","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.trecan.2023.01.002_bb0265","doi-asserted-by":"crossref","first-page":"10862","DOI":"10.1158\/0008-5472.CAN-05-1231","article-title":"Stromelysin-3 is a potent negative regulator of adipogenesis participating to cancer cell-adipocyte interaction\/crosstalk at the tumor invasive front","volume":"65","author":"Andarawewa","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.trecan.2023.01.002_bb0270","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.571948","article-title":"The adipose microenvironment dysregulates the mammary myoepithelial cells and could participate to the progression of breast cancer","volume":"8","author":"Delort","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.trecan.2023.01.002_bb0275","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1158\/0008-5472.CAN-15-0927","article-title":"Interactions between adipocytes and breast cancer cells stimulate cytokine production and drive Src\/Sox2\/miR-302b\u2013mediated malignant progression","volume":"76","author":"Picon-Ruiz","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.trecan.2023.01.002_bb0280","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1007\/s10549-015-3326-2","article-title":"Targeting exosomes from preadipocytes inhibits preadipocyte to cancer stem cell signaling in early-stage breast cancer","volume":"150","author":"Gernapudi","year":"2015","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.trecan.2023.01.002_bb0285","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/s13058-017-0921-7","article-title":"Obesity reversibly depletes the basal cell population and enhances mammary epithelial cell estrogen receptor alpha expression and progenitor activity","volume":"19","author":"Chamberlin","year":"2017","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.trecan.2023.01.002_bb0290","doi-asserted-by":"crossref","first-page":"4270","DOI":"10.1200\/JCO.2016.67.4283","article-title":"Obesity and cancer mechanisms: tumor microenvironment and inflammation","volume":"34","author":"Iyengar","year":"2016","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.trecan.2023.01.002_bb0295","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1158\/1940-6207.CAPR-17-0245","article-title":"Macrophagic \u201ccrown-like structures\u201d are associated with an increased risk of breast cancer in benign breast disease","volume":"11","author":"Carter","year":"2018","journal-title":"Cancer Prev. Res."},{"key":"10.1016\/j.trecan.2023.01.002_bb0300","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201910491","article-title":"Macrophages induce malignant traits in mammary epithelium via IKK\u03b5\/TBK1 kinases and the serine biosynthesis pathway","volume":"12","author":"Wilcz-Villega","year":"2020","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.trecan.2023.01.002_bb0305","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1158\/1078-0432.CCR-15-2239","article-title":"Systemic correlates of white adipose tissue inflammation in early-stage breast cancer","volume":"22","author":"Iyengar","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.trecan.2023.01.002_bb0310","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s13058-020-01308-4","article-title":"Detection of crown-like structures in breast adipose tissue and clinical outcomes among African-American and White women with breast cancer","volume":"22","author":"Maliniak","year":"2020","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.trecan.2023.01.002_bb0315","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/s41523-021-00232-w","article-title":"Breast adipocyte size associates with ipsilateral invasive breast cancer risk after ductal carcinoma in situ","volume":"7","author":"Almekinders","year":"2021","journal-title":"npj Breast Cancer"},{"key":"10.1016\/j.trecan.2023.01.002_bb0320","doi-asserted-by":"crossref","first-page":"3593","DOI":"10.1158\/1078-0432.CCR-18-0201","article-title":"Clinicopathological risk factors for an invasive breast cancer recurrence after ductal carcinoma in situ\u2014a nested case\u2013control study","volume":"24","author":"Visser","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.trecan.2023.01.002_bb0325","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.trecan.2023.01.002_bb0330","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1158\/2326-6066.CIR-19-0786","article-title":"Immune escape during breast tumor progression","volume":"8","author":"Gil Del Alcazar","year":"2020","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.trecan.2023.01.002_bb0335","doi-asserted-by":"crossref","first-page":"797","DOI":"10.3892\/ijo.2015.3075","article-title":"The role of inflammation in progression of breast cancer: Friend or foe? (Review)","volume":"47","author":"Allen","year":"2015","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.trecan.2023.01.002_bb0340","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s10549-014-3185-2","article-title":"The prognostic value of tumor-infiltrating lymphocytes in triple-negative breast cancer: a meta-analysis","volume":"148","author":"Ibrahim","year":"2014","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.trecan.2023.01.002_bb0345","doi-asserted-by":"crossref","first-page":"2959","DOI":"10.1200\/JCO.2013.55.0491","article-title":"Prognostic value of tumor-infiltrating lymphocytes in triple-negative breast cancers from two phase III randomized adjuvant breast cancer trials: ECOG 2197 and ECOG 1199","volume":"32","author":"Adams","year":"2014","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.trecan.2023.01.002_bb0350","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13058-020-01267-w","article-title":"Immune microenvironment in ductal carcinoma in situ: a comparison with invasive carcinoma of the breast","volume":"22","author":"Kim","year":"2020","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.trecan.2023.01.002_bb0355","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1158\/2159-8290.CD-17-0222","article-title":"Immune escape in breast cancer during in situ to invasive carcinoma transition","volume":"7","author":"Gil Del Alcazar","year":"2017","journal-title":"Cancer Discov."},{"key":"10.1016\/j.trecan.2023.01.002_bb0360","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1007\/s00428-019-02735-1","article-title":"Higher density of stromal M2 macrophages in breast ductal carcinoma in situ predicts recurrence","volume":"476","author":"Chen","year":"2020","journal-title":"Virchows Arch."},{"key":"10.1016\/j.trecan.2023.01.002_bb0365","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s41467-017-02481-5","article-title":"Macrophages orchestrate breast cancer early dissemination and metastasis","volume":"9","author":"Linde","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.trecan.2023.01.002_bb0370","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s10549-016-4036-0","article-title":"Characterizing the immune microenvironment in high-risk ductal carcinoma in situ of the breast","volume":"161","author":"Campbell","year":"2017","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.trecan.2023.01.002_bb0375","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1093\/jnci\/86.8.614","article-title":"Microvessel density and distribution in ductal carcinoma in situ of the breast","volume":"86","author":"Guidi","year":"1994","journal-title":"JNCI: J. Natl. Cancer Inst."},{"key":"10.1016\/j.trecan.2023.01.002_bb0380","article-title":"Prognostic significance of high VEGF-C expression for patients with breast cancer: an update meta analysis","volume":"11","author":"Zhang","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.trecan.2023.01.002_bb0385","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/(SICI)1096-9896(199702)181:2<207::AID-PATH758>3.0.CO;2-4","article-title":"Distinct angiogenic patterns are associated with high-grade in situ ductal carcinomas of the breast","volume":"181","author":"Engels","year":"1997","journal-title":"J. Pathol."},{"key":"10.1016\/j.trecan.2023.01.002_bb0390","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1002\/(SICI)1096-9896(199702)181:2<200::AID-PATH726>3.0.CO;2-K","article-title":"Angiogenesis and inflammation in ductal carcinoma in situ of the breast","volume":"181","author":"Lee","year":"1997","journal-title":"J. Pathol."},{"key":"10.1016\/j.trecan.2023.01.002_bb0395","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S0959-8049(02)00248-4","article-title":"Angiogenesis and invasive recurrence in ductal carcinoma in situ of the breast","volume":"39","author":"Teo","year":"2003","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.trecan.2023.01.002_bb0400","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1038\/sj.bjc.6602567","article-title":"Expression patterns of angiogenic and lymphangiogenic factors in ductal breast carcinoma in situ","volume":"92","author":"W\u00fclfing","year":"2005","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.trecan.2023.01.002_bb0405","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/(SICI)1096-9896(199902)187:3<285::AID-PATH238>3.0.CO;2-R","article-title":"Angiogenesis and expression of thymidine phosphorylase by inflammatory and carcinoma cells in ductal carcinoma in situ of the breast","volume":"187","author":"Lee","year":"1999","journal-title":"J. Pathol."},{"key":"10.1016\/j.trecan.2023.01.002_bb0410","doi-asserted-by":"crossref","first-page":"3449","DOI":"10.1038\/sj.onc.1203677","article-title":"The human myoepithelial cell displays a multifaceted anti-angiogenic phenotype","volume":"19","author":"Nguyen","year":"2000","journal-title":"Oncogene"},{"key":"10.1016\/j.trecan.2023.01.002_bb0415","doi-asserted-by":"crossref","first-page":"E2595","DOI":"10.1073\/pnas.1212834109","article-title":"ECM microenvironment regulates collective migration and local dissemination in normal and malignant mammary epithelium","volume":"109","author":"Nguyen-Ngoc","year":"2012","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.trecan.2023.01.002_bb0420","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/sj.bjc.6601990","article-title":"Protein and mRNA expression of uPAR and PAI-1 in myoepithelial cells of early breast cancer lesions and normal breast tissue","volume":"91","author":"Hildenbrand","year":"2004","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.trecan.2023.01.002_bb0425","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1242\/dev.087643","article-title":"Mammary gland development: cell fate specification, stem cells and the microenvironment","volume":"142","author":"Inman","year":"2015","journal-title":"Development"},{"key":"10.1016\/j.trecan.2023.01.002_bb0430","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1083\/jcb.200302090","article-title":"Site-specific inductive and inhibitory activities of MMP-2 and MMP-3 orchestrate mammary gland branching morphogenesis","volume":"162","author":"Wiseman","year":"2003","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.trecan.2023.01.002_bb0435","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s10555-018-9768-3","article-title":"Cancer-associated fibroblasts as key regulators of the breast cancer tumor microenvironment","volume":"37","author":"Houthuijzen","year":"2018","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.trecan.2023.01.002_bb0440","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.devcel.2018.08.025","article-title":"Divergent matrix-remodeling strategies distinguish developmental from neoplastic mammary epithelial cell invasion programs","volume":"47","author":"Feinberg","year":"2018","journal-title":"Dev. Cell"},{"key":"10.1016\/j.trecan.2023.01.002_bb0445","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/s41568-019-0238-1","article-title":"A framework for advancing our understanding of cancer-associated fibroblasts","volume":"20","author":"Sahai","year":"2020","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.trecan.2023.01.002_bb0450","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/nrc.2016.73","article-title":"The biology and function of fibroblasts in cancer","volume":"16","author":"Kalluri","year":"2016","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.trecan.2023.01.002_bb0455","first-page":"205","article-title":"Taxotere-induced WNT16 expression in carcinoma-associated fibroblasts might associate with progression and chemoresistance of breast cancer","volume":"50","author":"Xiang","year":"2020","journal-title":"Ann. Clin. Lab. Sci."},{"key":"10.1016\/j.trecan.2023.01.002_bb0460","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.ccell.2018.01.011","article-title":"Fibroblast heterogeneity and immunosuppressive environment in human breast cancer","volume":"33","author":"Costa","year":"2018","journal-title":"Cancer Cell"},{"key":"10.1016\/j.trecan.2023.01.002_bb0465","doi-asserted-by":"crossref","first-page":"R3","DOI":"10.1186\/bcr2218","article-title":"Novel multicellular organotypic models of normal and malignant breast: tools for dissecting the role of the microenvironment in breast cancer progression","volume":"11","author":"Holliday","year":"2009","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.trecan.2023.01.002_bb0470","doi-asserted-by":"crossref","first-page":"3372","DOI":"10.1073\/pnas.0813306106","article-title":"Role of COX-2 in epithelial-stromal cell interactions and progression of ductal carcinoma in situ of the breast","volume":"106","author":"Hu","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.trecan.2023.01.002_bb0475","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1186\/s12885-015-1576-3","article-title":"Il-6 signaling between ductal carcinoma in situ cells and carcinoma-associated fibroblasts mediates tumor cell growth and migration","volume":"15","author":"Osuala","year":"2015","journal-title":"BMC Cancer"},{"key":"10.1016\/j.trecan.2023.01.002_bb0480","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s10911-018-9407-1","article-title":"CXCL1 derived from mammary fibroblasts promotes progression of mammary lesions to invasive carcinoma through CXCR2 dependent mechanisms","volume":"23","author":"Bernard","year":"2018","journal-title":"J. Mammary Gland Biol. Neoplasia"},{"key":"10.1016\/j.trecan.2023.01.002_bb0485","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1158\/1541-7786.MCR-17-0308","article-title":"Chemokine signaling facilitates early-stage breast cancer survival and invasion through fibroblast-dependent mechanisms","volume":"16","author":"Brummer","year":"2018","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.trecan.2023.01.002_bb0490","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1093\/jnci\/djy234","article-title":"Impact of epithelial-stromal interactions on peritumoral fibroblasts in ductal carcinoma in situ","volume":"111","author":"Strell","year":"2019","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.trecan.2023.01.002_bb0495","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.4161\/cbt.8.11.8874","article-title":"Stromal caveolin-1 levels predict early DCIS progression to invasive breast cancer","volume":"8","author":"Witkiewicz","year":"2009","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.trecan.2023.01.002_bb0500","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1016\/j.devcel.2022.09.016","article-title":"MYO10-filopodia support basement membranes at pre-invasive tumor boundaries","volume":"57","author":"Peuhu","year":"2022","journal-title":"Dev. Cell"},{"key":"10.1016\/j.trecan.2023.01.002_bb0505","doi-asserted-by":"crossref","first-page":"5120","DOI":"10.1038\/s41467-020-18794-x","article-title":"Concepts of extracellular matrix remodelling in tumour progression and metastasis","volume":"11","author":"Winkler","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.trecan.2023.01.002_bb0510","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1007\/s10555-016-9650-0","article-title":"From transformation to metastasis: deconstructing the extracellular matrix in breast cancer","volume":"35","author":"Kaushik","year":"2016","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.trecan.2023.01.002_bb0515","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1039\/c5ib00040h","article-title":"Human breast cancer invasion and aggression correlates with ECM stiffening and immune cell infiltration","volume":"7","author":"Acerbi","year":"2015","journal-title":"Integr. Biol. (Camb.)"},{"key":"10.1016\/j.trecan.2023.01.002_bb0520","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/j.ajpath.2010.11.076","article-title":"Aligned collagen is a prognostic signature for survival in human breast carcinoma","volume":"178","author":"Conklin","year":"2011","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.trecan.2023.01.002_bb0525","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1741-7015-4-38","article-title":"Collagen reorganization at the tumor-stromal interface facilitates local invasion","volume":"4","author":"Provenzano","year":"2006","journal-title":"BMC Med."},{"key":"10.1016\/j.trecan.2023.01.002_bb0530","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1038\/s41388-022-02258-1","article-title":"Spatial collagen stiffening promotes collective breast cancer cell invasion by reinforcing extracellular matrix alignment","volume":"41","author":"Koorman","year":"2022","journal-title":"Oncogene"},{"key":"10.1016\/j.trecan.2023.01.002_bb0535","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1158\/1055-9965.EPI-17-0720","article-title":"Collagen alignment as a predictor of recurrence after ductal carcinoma in situ","volume":"27","author":"Conklin","year":"2018","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"10.1016\/j.trecan.2023.01.002_bb0540","doi-asserted-by":"crossref","first-page":"4587","DOI":"10.1038\/s41467-022-32255-7","article-title":"Temporal profiling of the breast tumour microenvironment reveals collagen XII as a driver of metastasis","volume":"13","author":"Papanicolaou","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.trecan.2023.01.002_bb0545","doi-asserted-by":"crossref","first-page":"3509","DOI":"10.1083\/jcb.201702033","article-title":"Cancer-associated fibroblasts lead tumor invasion through integrin-\u03b23-dependent fibronectin assembly","volume":"216","author":"Attieh","year":"2017","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.trecan.2023.01.002_bb0550","doi-asserted-by":"crossref","first-page":"2772","DOI":"10.1038\/s41388-020-1192-9","article-title":"Postpartum breast cancer progression is driven by semaphorin 7a-mediated invasion and survival","volume":"39","author":"Tarullo","year":"2020","journal-title":"Oncogene"},{"key":"10.1016\/j.trecan.2023.01.002_bb0555","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s13058-016-0703-7","article-title":"Neutrophils drive accelerated tumor progression in the collagen-dense mammary tumor microenvironment","volume":"18","author":"Garc\u00eda-Mendoza","year":"2016","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.trecan.2023.01.002_bb0560","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a003228","article-title":"Mammary gland ECM remodeling, stiffness, and mechanosignaling in normal development and tumor progression","volume":"3","author":"Schedin","year":"2011","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.trecan.2023.01.002_bb0565","doi-asserted-by":"crossref","first-page":"4597","DOI":"10.1158\/0008-5472.CAN-13-3698","article-title":"Force engages vinculin and promotes tumor progression by enhancing PI3K activation of phosphatidylinositol (3, 4, 5)-triphosphate","volume":"74","author":"Rubashkin","year":"2014","journal-title":"Cancer Res."},{"key":"10.1016\/j.trecan.2023.01.002_bb0570","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.trecan.2021.06.009","article-title":"Tumour microenvironment 3D-modelling: simplicity to complexity and back again","volume":"7","author":"Carter","year":"2021","journal-title":"Trends Cancer"},{"key":"10.1016\/j.trecan.2023.01.002_bb0575","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13058-017-0843-4","article-title":"A 3D in vitro model of the human breast duct: a method to unravel myoepithelial-luminal interactions in the progression of breast cancer","volume":"19","author":"Carter","year":"2017","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.trecan.2023.01.002_bb0580","doi-asserted-by":"crossref","first-page":"4153","DOI":"10.1073\/pnas.1703931114","article-title":"SMARCE1 is required for the invasive progression of in situ cancers","volume":"114","author":"Sokol","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.trecan.2023.01.002_bb0585","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s13058-016-0677-5","article-title":"Growth of human breast tissues from patient cells in 3D hydrogel scaffolds","volume":"18","author":"Sokol","year":"2016","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.trecan.2023.01.002_bb0590","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.ccell.2016.02.002","article-title":"A preclinical model for ER\u03b1-positive breast cancer points to the epithelial microenvironment as determinant of luminal phenotype and hormone response","volume":"29","author":"Sflomos","year":"2016","journal-title":"Cancer Cell"},{"key":"10.1016\/j.trecan.2023.01.002_bb0595","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/path.5820","article-title":"Mouse-INtraDuctal (MIND): an in vivo model for studying the underlying mechanisms of DCIS malignancy","volume":"256","author":"Hong","year":"2022","journal-title":"J. Pathol."}],"container-title":["Trends in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S240580332300002X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S240580332300002X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T08:56:08Z","timestamp":1762505768000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S240580332300002X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":119,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["S240580332300002X"],"URL":"https:\/\/doi.org\/10.1016\/j.trecan.2023.01.002","relation":{},"ISSN":["2405-8033"],"issn-type":[{"value":"2405-8033","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Everybody needs good neighbours: the progressive DCIS microenvironment","name":"articletitle","label":"Article Title"},{"value":"Trends in Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trecan.2023.01.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}